In this interactive CMEO BriefCase, learners will meet Tom, a 44-year-old man who presents with persistent pain of over 3 months duration that intensifies with elbow flexion and wrist extension. Dr. Hegarty will guide learners through an appropriate assessment of the pain and work through decision points of the case to develop a multimodal treatment strategy with the goal of restoring function and quality of life.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
Supported by an educational grant from BioWave.
Physicians, PAs, nurse practitioners, and pharmacists
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Hegarty reports that he receives unrestricted educational grants from Grunenthal to University College Cork. He is on the speakers bureau for Epimed/Racz Workshops; Medtronic and Platform-14. He is a consultant for Capri Medical and Platform-14. He receives other financial or material support as Honorary Treasurer and Board Member, World Institute of Pain (WIP).
Disclosures were obtained from the CME Outfitters, LLC, staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-160-H01-P
Call us at 877.CME.PROS (877.263.7767).